Abstracts » Health

Screening for chlamydia trachomatis infection in pregnant women in Martinique

Article Abstract:

Routinely testing for chlamydia infections in pregnant women may be a cost-effective way to control the spread of this disease in high-risk areas. Chlamydia is a sexually transmitted bacterial disease affecting the cervix and urinary tract. Chlamydia infection rates of pregnant widely vary around the world, from 2% to 50%. Pregnant women with chlamydia can experience complications with present and future deliveries. Infants born to women with chlamydia may have middle ear infections, lung diseases, or may die. Researchers tested and interviewed 1411 pregnant women for chlamydia infection on the intermediately developed island of Martinique. Nearly 27% of these women tested positive for chlamydia. Risk factors associated with this disease were having first intercourse before age 18, age less than 25 years, previous abortions, cervical infections, and previous candida infections. Treating complicated chlamydia infections during pregnancy could cost as much as 5 times that of testing and routine treatment.

Health aspects, Martinique

---

Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic

Article Abstract:

Routine screening for Chlamydia trachomatis in men attending sexually transmitted diseases (STD) clinics could detect unsuspected cases, but may not be cost-effective.Of 9,662 men screened for C. trachomatis by a direct fluorescent antibody (DFA) test at a STD clinic, 474 were positive. Of these, 93.7% were treated immediately due to clinic protocols directing the presumptive treatment of chlamydia for those meeting certain other criteria. Although 40% of the men infected with C. trachomatis had no symptoms, only 6.3% would not have been treated effectively. African-Americans under age 24 were most likely to be infected.

Testing, Chlamydia trachomatis

---

Completeness of and Duration of Time Before Treatment After Screening Women for Chlamydia trachomatis Infections

Article Abstract:

There is often a delay between the time a woman tests positive for chlamydia infection and the time she receives treatment. In a survey of 4,158 women who tested positive for chlamydia, only 24% received a prescription for antibiotics on the day they were tested. Sexually transmitted disease clinics did the best, giving 71% of the women they tested a prescription on the day they were tested. Public family planning clinics did the worst, with an average delay of 26 days between the test and the treatment.

Some parts © 2012 Advameg, Inc.